These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 19223491)
1. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma. Erdogan E; Klee EW; Thompson EA; Fields AP Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491 [TBL] [Abstract][Full Text] [Related]
2. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Justilien V; Fields AP Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897 [TBL] [Abstract][Full Text] [Related]
3. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer. Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma. Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. Justilien V; Jameison L; Der CJ; Rossman KL; Fields AP J Biol Chem; 2011 Mar; 286(10):8149-8157. PubMed ID: 21189248 [TBL] [Abstract][Full Text] [Related]
6. Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma. Ali SA; Justilien V; Jamieson L; Murray NR; Fields AP Cancer Cell; 2016 Mar; 29(3):367-378. PubMed ID: 26977885 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Frederick LA; Matthews JA; Jamieson L; Justilien V; Thompson EA; Radisky DC; Fields AP Oncogene; 2008 Aug; 27(35):4841-53. PubMed ID: 18427549 [TBL] [Abstract][Full Text] [Related]
8. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers. Liu Y; Justilien V; Fields AP; Murray NR Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies. Yin N; Liu Y; Murray NR; Fields AP Adv Biol Regul; 2020 Jan; 75():100656. PubMed ID: 31623973 [TBL] [Abstract][Full Text] [Related]
10. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062 [TBL] [Abstract][Full Text] [Related]
11. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma. Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680 [TBL] [Abstract][Full Text] [Related]
12. Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter. Gustafson WC; Ray S; Jamieson L; Thompson EA; Brasier AR; Fields AP J Biol Chem; 2004 Mar; 279(10):9400-8. PubMed ID: 14670960 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis. Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210 [TBL] [Abstract][Full Text] [Related]
14. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma. Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987 [TBL] [Abstract][Full Text] [Related]
15. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237 [TBL] [Abstract][Full Text] [Related]
16. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis. Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186 [TBL] [Abstract][Full Text] [Related]
17. PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. Wang Y; Hill KS; Fields AP Mol Cancer Res; 2013 Dec; 11(12):1624-35. PubMed ID: 24174471 [TBL] [Abstract][Full Text] [Related]
18. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246 [TBL] [Abstract][Full Text] [Related]
19. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer. Fields AP; Frederick LA; Regala RP Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262 [TBL] [Abstract][Full Text] [Related]
20. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway. Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]